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ABSTRACT
Objective: The objective of the study was to evaluate the hypolipidemic activity of fruit rind extracts of Garcinia gummi-gutta in diet-induced 
hyperlipidemic rats.
Methods: Hydroalcoholic extract of fruit rinds of G. gummi-gutta was prepared using Soxhlet apparatus. 30 Wistar albino rats were divided into five 
groups (n=6). Except for Group 1, all the other groups were treated with hyperlipidemic diet (HLD) for 4 weeks. After induction, the Groups 3 and 4 
were treated with the extracts at 100 mg/kg and 200 mg/kg doses, respectively, whereas Group 5 received the standard drug atorvastatin at 10 mg/kg 
for the next 4 weeks. Lipid profile was estimated at the end of each week. At the end of the study, rats were sacrificed and the liver and heart were 
analyzed for histopathological changes. Data expressed as mean±standard error of the mean. Statistical analysis was done using one-way ANOVA 
followed by post hoc Tukey test. p<0.05 considered statistically significant.
Results: The serum levels of total cholesterol (TC), triglycerides (TG), very low-density lipoprotein (VLDL), and LDL were significantly 
increased and the levels of high-density lipoprotein (HDL) were significantly decreased when compared to normal control. The groups which 
received G. gummi-gutta rind extract at 100 mg/kg and 200 mg/kg showed a significant decrease in the mean cholesterol, TG, LDL, VLDL 
levels, and an increase in HDL levels when compared to the HLD group. The group which received the extract at higher dose (REGG200) was 
found better than the lower dose (REGG 100). REGG 200 showed significant improvement in increasing the HDL levels than all the test groups. 
The standard drug atorvastatin was found better than REGG100 but there was no significant difference between high doses of the extract and 
atorvastatin.
Conclusion: The fruit rinds extract of G. gummi-gutta was able to decrease the elevated serum lipids (TC, TG, LDL, and VLDL) and consequently 
increase the HDL levels in a dose-dependent manner.
Keywords: Garcinia gummi-gutta, Hypolipidemic, Atorvastatin, Lipid profile.
INTRODUCTION
Cardiovascular disease (CVD) was previously assumed to be a problem 
of developed and industrialized nations, but over the past few decades, 
it has slowly infiltrated into the low and middle-income countries where 
it accounts for nearly 30% of all deaths [1]. In India, the prevalence 
of CVD has grown exponentially and accounts for nearly 24% of all 
adult deaths [2]. Reports submitted by the National Commission on 
Macroeconomics and Health have estimated that there would be 
62 million patients with coronary artery disease by 2015 and of these 
23 million would be people younger than 40 years [3].
The umbrella term CVD has multifactorial etiopathogenesis and its 
prevalence is attributed to lifestyle changes due to urbanization, stress, 
lack of physical activity, nutritional transitions, and other metabolic 
disorders such as diabetes and hypothyroidism.
For decades, dyslipidemia has been identified as an independent 
modifiable risk closely associated with the incidence of CVD. 
Furthermore, increased levels of low-density lipoprotein (LDL) with 
a concurrent decrease in high-density lipoprotein (HDL) contribute to 
the process of atherogenesis and evolution of atheromatous plaque [4].
Conventional preparations of lipid-lowering drugs such as statins, 
fibrates, bile acid sequestrants, and niacin are efficient in lowering 
serum lipids but not always free of side effects [5].
For many years plants and plant products have been identified as a 
potentially safer alternative to synthetic drugs. Despite such intensive 
research on various herbal medicines, many species of plants are still 
left unexplored.
Garcinia gummi-gutta also known as Garcinia cambogia is a 
diminutive purple fruit native to India and Southeast Asia. The 
fruit rinds find its use as a food preservative, flavoring agent, 
and carminative [6]. Traditionally, it is used for the treatment of 
constipation, piles, rheumatism, edema, menstrual abnormalities, 
and parasitic infestations [7]. Although many of its biological effects 
have been explored to depth, still satisfactory studies to exploit 
its hypolipidemic activity have not been conducted. Therefore, the 
present study was planned to evaluate the hypolipidemic activity of 
G. gummi-gutta fruit extract using animal models.
METHODS
Collection and identification of plant materials
The fruit of G. gummi-gutta was collected during the winter season in 
the month of August from Palode area of Thiruvananthapuram district, 
Kerala, India, and was authenticated by a local botanist from Science 
College. The fruit rinds weighing 5 kg were separated along the grooves 
and deseeded. They were later cleaned, shade dried, pulverized, and 
stored in airtight containers until the commencement of the extraction 
process.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Preparation of rind extract
Hydroalcoholic extract was prepared as per the procedure elaborated 
by Mahanta and Mukherjee [8]. About 40–45 g of dried powder was 
packed in the thimble of Soxhlet apparatus, and extraction was carried 
out continuously with 95% ethanol refluxing at 50–70°C which yielded 
a dark brown sticky mass. The extract was concentrated and dried 
using a ventilated oven at 45°C for 24 h. The stock powder was stored 
in a glass desiccator at 4°C. The total yield per cycle was around 15% 
(~6 g) per cycle.
Chemicals
Pure cholesterol and cholic acid were obtained from Loba Chemie 
Pvt., Ltd., Mumbai. Atorvastatin (Lipvas) of Cipla Company, Mumbai, 
was procured from a local medical store. 2-thiobarbituric acid was 
purchased from Sigma Aldrich, Bengaluru. All other solvents and 
chemicals used in the study were of analytical grade and purchased 
from SD fine - chem. Mumbai.
Ethical clearance
Ethical clearance was taken from Institutional Animal Ethics Committee 
of the institute before the commencement of the study.
Animals
Adult male Wistar albino rats 10–12 weeks of age weighing 180±20 g 
were procured from King’s Institute, Guindy, Chennai. They were 
housed and maintained in the central animal house of the institute 
2 weeks before the commencement of the study so that they could 
adapt to the new environment. Animals were kept in polypropylene 
cages with dry paddy husk bedding maintaining a room temperature 
of 26±2°C and relative humidity of 45–55% with 12:12 h dark and light 
cycle. They were fed with standard pellet diet and water ad libitum. The 
nutritional value of the standard pellet diet was 21% of protein, 5% of 
lipids, 4% of crude fiber, 8% of ash, 1% of calcium, 0.6% of phosphorus, 
3.4% of glucose, 2% of vitamins, 55% of carbohydrates, and produced 
energy of 3600 kcal/kg. Care of the animals in the central animal house 
was strictly in accordance with the guidelines drafted by the Committee 
for the purpose of Control and Supervision of Experiments on Animals, 
New Delhi, India.
Acute toxicity testing
A pilot study was performed using two doses 1000 mg/kg body 
weight and 2000 mg/kg body weight of the fruit rind extract of 
G. gummi-gutta. The doses selected were 10 and 20 times more than 
the earlier study. The animals were observed continuously for 4 h and 
then occasionally for further 4 h and finally overnight. Animals were 
observed for tremors, clonic convulsions, tonic extensions, catatonia, 
spasticity, opisthotonus, ataxia, sedation, ptosis, and respiration. The 
animals were continuously observed for 24 and 72 h for any lethality 
or death.
Dose selection
As the limit dose did not exhibit any signs of toxicity, a dose of 200 and 
100 mg/kg, p.o., which was 1/10th and 1/20th of 2000 mg/kg, was taken 
up for the main study. Atorvastatin at a dose of 10 mg/kg was taken as 
standard control.
Hyperlipidemic diet (HLD)
Method of Blank with modification was used to produce diet-induced 
hyperlipidemia. HLD was prepared daily by mixing standard pellet diet 
(92%), cholesterol (2%), cholic acid (1%), and coconut oil (5%) and 
was molded into pellets [9].
Experimental design
A total of 30 healthy adult Wistar albino rats were used in the study. 
The total duration of the study was 8 weeks. Following acclimatization 
for 1 week, a baseline measurement of lipid profile was performed for 
all the rats. In an attempt to eliminate bias, the rats were numbered 
and grouped based on random numbers generated using computer 
software.
Induction of hyperlipidemia
The study consists of five groups with six rats in each group (n=6). 
Except for Group 1 which received standard pellet diet and water 
ad libitum, all the remaining four groups received HLD for a period of 
30 days.
On day 30, the lipid profile of the rats in all the four groups was 
estimated and induction of hyperlipidemia was confirmed.
Following successful induction, the rats belonging to those four groups 
were treated with the extracts, and the standard drug between 9 and 
10 am daily for another 30 days suspended in 1% carboxymethylcellulose 
and administered using a steel gavage needle (Table 1).
Estimation of lipid profile
Blood samples for the estimation of lipid profile were taken from the 
lateral tail vein as per method elaborated by Diehl et al. [10]. Blood 
samples were collected on day 0 (baseline) and thereafter on 30th, 45th, 
and 60th day. Serum was separated by centrifugation at 3000 rpm for 
10 min. It was then kept frozen at −20°C until analysis. Total cholesterol 
(TC) level was calculated by the enzymatic method and expressed 
in mg/dl. HDL levels were calculated using polyanion precipitation 
and expressed as mg/dl. LDL cholesterol level was calculated using 
Friedewald’s equation and expressed in mg/dl. Triglycerides (TG) in 
serum were converted to glycerol and then estimated using glycerol 
kinase enzyme based kinetic method and expressed in mg/dl. Very LDL 
is calculated using the formula:
VLDL TG=
5
At the end of 8 weeks, all the rats were sacrificed by an overdose of 
sodium pentobarbital 150 mg/kg i.p. Heart and liver were dissected 
and washed with the physiological salt solution and fixed with 10% 
formalin.
Thiobarbituric acid reactive substances (TBARS) assay
About 1 ml of serum was mixed with 500 μl of 15% trichloroacetic acid 
in 0.25 N hydrochloric acid (HCl) and 500 μl of 0.375% thiobarbituric 
acid in 0.25 N HCl. This was shaken well to mix thoroughly and was 
then heated in a boiling water bath at 95°C for 15 min. After bringing it 
down to room temperature, it was centrifuged at 1000 r.p.m for 10 min 
and the reddish-pink supernatant was collected. Absorbance was 
determined using Labman double beam UV-visible spectrophotometer 
(LMSP-UV1900) tuned to a wavelength (λ) at 535 nm against a blank 
that contained all the reagents minus the serum [11]. The concentration 
of malondialdehyde (MDA) in the serum was calculated using molar 
extinction coefficient 1.56 M/cm, and the results were expressed in 
ηmol/ml of plasma [12].
Histopathology
The liver and heart fixed in 10% formalin were washed, dehydrated in 
descending grades of isopropanol and finally rinsed with xylene. The 
tissues were then embedded in molten paraffin wax. Sections were 
cut  using  a microtome  at  a  thickness  of  5  μm and  then  stained with 
Table 1: Experimental design
Group Purpose Treatment
Group 1 Normal control Standard pellet diet+1% CMC
Group 2 HLD control HLD+1% CMC
Group 3 REGG 100 HLD+rind extract of G. gummi-gutta 
at 100 mg/kg
Group 4 REGG 200 HLD+rind extract of G. gummi-gutta 
at 200 mg/kg
Group 5 Standard group HLD+Atorvastatin at 10 mg/kg
HLD: Hyperlipidemic diet, REGG100: Rind extract of Garcinia gummi-gutta 
at 100 mg/kg, REGG200: Rind extract of Garcinia gummi-gutta at 200 mg/kg, 
G. gummi-gutta: Garcinia gummi-gutta, CMC: Carboxymethylcellulose
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hematoxylin and eosin [13]. The sections were observed under light 
microscope at a magnification of ×10 (Adeltavision Trinocular Digital 
Microscope) for histopathological changes.
Statistical analysis
Collected data were entered in Microsoft Excel 2013 and analyzed 
using SPSS statistical software version 17. Results were expressed in 
mean±standard error of the mean as tables. Statistical analysis was 
performed using one way ANOVA followed by post hoc Tukey’s test. The 
p<0.05 was considered statistically significant at 95% confidence interval.
RESULTS
Acute toxicity study of REGG in rats
Acute toxicity studies confirmed that the fruit rind extract of 
G. gummigutta up to a dose of 2000 mg/kg body weight was non-toxic. 
No death was observed for up to 72 h. There was no lethality or any toxic 
reactions found at any of the doses selected until the end of the study.
Effect of the rind extract of G. gummi-gutta on serum lipid levels
The serum levels of TC, TG, VLDL, and LDL were significantly increased, 
and the levels of HDL were significantly decreased when compared to 
normal control.
The groups which received G. gummi-gutta rind extract at 100 mg/kg 
and 200 mg/kg showed a significant decrease in the mean cholesterol, 
TG, LDL, VLDL levels, and an increase in HDL levels when compared to 
the HLD group. The group which received the extract at higher dose 
(REGG200) was found better than the lower dose (REGG 100). REGG 
200 showed significant improvement in increasing the HDL levels than 
all the test groups.
The standard drug atorvastatin was found better than REGG100, but 
there was no significant difference between a high dose of G. gummi-
gutta rind extract and atorvastatin. REGG 200 mg/kg showed a marginal 
increase in HDL levels than the standard drug (Tables 2-6).
Effect of the rind extract of G. gummi-gutta on TBARS levels
Serum  TBARS  levels  were  significantly  higher  (3.42±0.04  ηmol/ml) 
in rats treated with HLD. Hyperlipidemia significantly increased lipid 
peroxidation with the generation of reactive oxygen species due to 
decreased innate antioxidant activity. The groups treated with the 
standard drug atorvastatin and the groups treated with REGG at 
both doses showed a significant decrease in TBARS levels (p<0.001) 
when compared to HLD control. The concentration of MDA in REGG 
200 (1.03±0.01 ηmol/ml) was significantly lower when compared with 
other groups (Fig. 1).
Table 2: Effect of fruit rind extract of Garcinia gummi-gutta on total cholesterol levels
Groups (n=6) Total cholesterol levels (mg/dl)
Induction of hyperlipidemia Drug administration
Day 0 baseline Day 30 Day 45 Day 60
Group 1: Normal control 62.67±1.50 61.67±1.73 64.50±1.38 65.50±0.81
Group 2: HLD control 64.00±0.97 128.83±1.08 135.67±0.84## 141.33±1.23
Group 3: REGG 100 65.33±0.71 131.83±1.17 127.50±0.76**,## 109.17±1.30**,##
Group 4: REGG 200 64.17±1.17 129.33±0.49 113.17±0.91**,## 99.33±1.26**,##
Group 5: Standard control 65.83±1.66 129.00±1.18 106.00±0.97** 93.67±0.80**
Data expressed as mean±SEM. n=6 in each group. Significance at *p<0.05, **p<0.001 as compared to HLD control, #p<0.05, ##p<0.001 as compared to standard control. 
HLD: Hyperlipidemic diet, REGG 100 and REGG 200: Rind extract of Garcinia gummi-gutta at 100 mg/kg and 200 mg/kg, Standard control: Atorvastatin 10 mg/kg, 
SEM: Standard error of mean
Table 3: Effect of fruit rind extract of Garcinia gummi‑gutta on triglyceride levels
Groups (n=6) Triglyceride levels (mg/dl)
Induction of hyperlipidemia Drug administration
Day 0 baseline Day 30 Day 45 Day 60
Group 1: Normal control 79.83±1.25 79.67±1.28 80.50±0.96 82.33±1.09
Group 2: HLD control 83.83±0.87 182.50±1.18 197.83±2.95## 204.00±3.22
Group 3: REGG 100 81.67±0.88 181.50±1.12 165.17±1.47**,## 148.50±1.77**,##
Group 4: REGG 200 81.17±1.08 179.83±1.30 143.33±1.45**,## 115.33±1.26**,##
Group 5: Standard control 83.50±0.76 180.50±0.76 120.17±1.30**,## 106.17±1.28**
Data expressed as mean±SEM. n=6 in each group. Significance at *p<0.05, **p<0.001 as compared to HLD control. #p<0.05, ##p<0.001 as compared to standard control. 
HLD: Hyperlipidemic diet, REGG 100 and REGG 200: Rind extract of Garcinia gummi-gutta at 100 mg/kg and 200 mg/kg, Standard control: Atorvastatin 10 mg/kg, 
SEM: Standard error of mean
Table 4: Effect of fruit rind extract of Garcinia gummi-gutta on low‑density lipoprotein cholesterol levels
Groups (n=6) LDL levels (mg/dl)
Induction of hyperlipidemia Drug administration
Day 0 baseline Day 30 Day 45 Day 60
Group 1: Normal control 18.53±2.06 17.57±1.98 19.90±1.45 19.03±0.86
Group 2: HLD control 22.23±1.17 63.83±2.17 72.27±0.31## 75.70±1.41
Group 3: REGG 100 22.17±1.31 66.53±1.74 60.97±0.76**,## 43.30±1.79**,##
Group 4: REGG 200 21.77±1.04 65.87±1.59 46.50±0.85**,## 31.10±1.85**
Group 5: Standard control 23.13±1.67 62.90±1.77 40.30±0.95** 30.27±1.61**
Data expressed as mean±SEM. n=6 in each group. Significance at *p<0.05, **p<0.001 as compared to HLD control. #p<0.05, ##p<0.001 as compared to standard control. 
HLD: Hyperlipidemic diet, REGG 100 and REGG 200: Rind extract of Garcinia gummi-gutta at 100 mg/kg and 200 mg/kg, Standard control: Atorvastatin 10 mg/kg, 
LDL: Low-density lipoprotein cholesterol, SEM: Standard error of mean
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Effect of the rind extract of G. gummi-gutta on liver histopathology
Histology of liver section of normal control exhibited normal hepatic 
cells each with well defined cytoplasm, prominent nucleus, and 
nucleolus with well defined central vein and sinusoids (Fig 2a). Rats 
which received HLD showed micro fatty deposits in the hepatocytes, 
congestion with mild distortion of the architecture, and early feathery 
degeneration (Fig. 2b). Hyperlipidemic rats which received REGG 
100 showed mild cytoplasmic fatty deposits and periportal leucocyte 
infiltration (Fig. 2c), whereas hyperlipidemic rats which received 
REGG 200 showed mild periportal inflammation with infiltration 
of lymphocytes with well-preserved liver architecture (Fig. 2d). 
Histopathology of rats treated with HLD along with atorvastatin 
showed only mild sinusoidal congestion with overall preservation of 
normal hepatic architecture (Fig. 2e).
Effect of the rind extract of G. gummi-gutta on myocardial 
histopathology
Histopathological sections of the heart did not show significant 
changes. Fig. 3a shows normal histology of myocardial cells. Oval-
elongated nucleus centrally surrounded with homogenous cytoplasm. 
Table: 5: Effect of fruit rind extract of Garcinia gummi-gutta on VLDL cholesterol levels
Groups (n=6) VLDL levels (mg/dl)
Induction of hyperlipidemia Drug administration
Day 0 baseline Day 30 Day 45 Day 60
Group 1: Normal control 15.97±0.25 15.93±0.26 16.10±0.19 16.47±0.22
Group 2: HLD control 16.77±0.17 36.50±0.24 39.57±0.59## 40.80±0.64##
Group 3: REGG 100 16.33±0.18 36.30±0.22 33.03±0.29**,## 29.70±0.35**,##
Group 4: REGG 200 16.23±0.22 35.97±0.26 28.67±0.29**,## 23.07±0.25**,#
Group 5: Standard control 16.70±0.15 36.10±0.15 24.03±0.26** 21.23±0.26**
Data expressed as mean±SEM. n=6 in each group. Significance at *p<0.05, **p<0.001 as compared to HLD control, #p<0.05, ##p<0.001 as compared to standard control. 
HLD: Hyperlipidemic diet, REGG 100 and REGG 200: Rind extract of Garcinia gummi-gutta at 100 mg/kg and 200 mg/kg, Standard control: Atorvastatin 10 mg/kg, 
VLDL: Very low-density lipoprotein cholesterol, SEM: Standard error of mean
Table 6: Effect of fruit rind extract of Garcinia gummi-gutta on high‑density lipoprotein cholesterol levels
Groups (n=6) HDL levels (mg/dl)
Induction of hyperlipidemia Drug administration
Day 0 baseline Day 30 Day 45 Day 60
Group 1: Normal control 28.17±0.87 28.17±0.54 28.50±0.76 30.00±0.63
Group 2: HLD control 25.00±0.58 27.00±1.26 23.83±1.08## 24.83±1.72
Group 3: REGG 100 26.83±1.01 29.00±0.86 33.50±0.67**,## 36.17±0.98**,#
Group 4: REGG 200 26.17±1.17 27.50±1.48 37.83±1.25**,## 45.17±1.30**
Group 5: Standard control 26.00±0.86 30.00±1.13 41.67±0.88** 42.17±1.22**
Data expressed as mean±SEM. n=6 in each group. Significance at *p<0.05,**p<0.001 as compared to HLD control, #p<0.05, ##p<0.001 as compared to standard control. 
HLD: Hyperlipidemic diet, REGG 100 and REGG 200: Rind extract of Garcinia gummi-gutta at 100 mg/kg and 200 mg/kg, Standard control: Atorvastatin 10 mg/kg, 
HDL: High-density lipoprotein cholesterol, SEM: Standard error of mean
Fig. 1: Effect of fruit rinds of Garcinia gummi-gutta on thiobarbituric acid reactive substances levels. Values expressed in ηmol/ml. n=6 
in each group. HLD ‑ hyperlipidemic diet, REGG 100 and REGG 200 ‑ rind extract of G. gummi-gutta at 100 mg/kg and 200 mg/kg
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Mild congestion with inflammatory infiltrates was seen with rats which 
received HLD (Fig. 3b). Hyperlipidemic rats which received the extracts 
at both doses and the standard control group failed to produce significant 
changes preserving the overall myocardial integrity (Fig. 3c-e).
The extract at both doses not only halted the inflammatory process but 
was also able to reverse the condition. This provides conclusive evidence 
of the hepatoprotective and cardioprotective property of the extract.
DISCUSSION
In the present study, the hypolipidemic activity of fruit rind extract of 
G. gummi-gutta was investigated in diet-induced hyperlipidemic rat 
models.
The 8-week study was conducted in the Department of Pharmacology 
in collaboration with the Department of Pathology and Biochemistry in 
Mahatma Gandhi Medical College and Research Institute, Puducherry.
In our study, supplementation of fruit rind extract at two doses, that 
is, 100 and 200 mg/kg, produced a dose-dependent reduction in the 
serum lipids along with significant reduction in lipid peroxidation.
In spite of daily HLD feeding, by the end of day 60, there was a significant 
reduction of TC, TG, and VLDL in Group 3 with REGG administered at 
a lower dose (100 mg/kg). When given at a higher dose (200 mg/kg) 
Group 4 exhibited a marked reduction in TC, TG, and VLDL as compared 
to Group 2 and significant reduction as compared with the standard 
drug atorvastatin.
The results suggest that REGG at both doses reduced the de novo 
cholesterol biosynthesis and favored the redistribution of cholesterol 
among the lipoprotein molecules. This activity can be attributed 
to the presence of hydroxycitric acid (HCA) in the extracts which 
competitively inhibits ATP citrate lyase, the enzyme responsible for 
the extramitochondrial degradation of citrate to oxaloacetate and 
acetyl CoA, thus limiting the availability of two carbon units required 
for fatty acid and cholesterol biosynthesis [6,14,15]. In addition to 
the above mechanism, HCA initiates gluconeogenesis by converting 
excess blood lipids to glycogen. It also inhibits pancreatic alpha-
amylase and intestinal glucosidase diminishing intestinal carbohydrate 
absorption [16], and exhibits partial inhibition of HMG-CoA reductase, 
the key enzyme in cholesterologenesis [17].
In our study, treatment with REGG led to a significant elevation of plasma 
HDL-cholesterol (HDL-CH) in spite of daily HLD feed. A proportionate 
increase in HDL levels was observed at the end of 6 weeks with the 
extracts given at both doses. However, by the end of 8 weeks, the levels 
of HDL in Group 4 showed significant increase than the standard drug.
Of late, the crucial risk factor for CVD has been identified to be a low 
level of HDL-CH. Decreased levels of HDL-CH play a direct role in the 
atherogenesis, and therapeutic interventions promoting HDL-CH levels 
is widely encouraged. HDL by counteracting LDL oxidation prevents 
atherogenesis and, recent studies suggest that HDL promotes the 
reverse cholesterol transport pathway, by inducing an efflux of excess 
accumulated cellular cholesterol and prevents the generation of 
oxidized-LDL [18]. Furthermore, HDL not only inhibits the oxidation of 
LDL but also prevents the 12-lipoxygenase-mediated formation of lipid 
hydroperoxides [19]. Based on this, our results clearly suggest that fruit 
rind extract of G. gummi-gutta may probably exert their antiatherogenic 
role, partly by the inhibition of lipids oxidation (evident by reduction in 
the TBARS levels), and partly by the elevation of HDL-C.
For ages, LDL-CH has been identified as a potential target in CVD risk 
reduction therapy. Elevated LDL levels augmented with oxidative stress 
increase the risk of atherosclerosis and CVD [20]. In our study, significant 
reduction in LDL levels was observed with REGG administered at both 
the doses. However, values obtained were comparable to that of the 
standard control following administration of the extracts at higher 
doses. The biocompound HCA may probably be responsible for the 
reduction in LDL levels [21].
Most of the findings, in our study, were inconsistent with previous 
works conducted by Mahendran and Devi who in his study observed 
that the rind extract of G. cambogia at 1000 mg/kg/day for 8 days 
showed notable hypolipidemic activity on dexamethasone-induced 
hyperlipidemic rats. He also found that the extract was capable of 
normalizing increased levels of cholesterol and TG as well as free fatty 
acid following dexamethasone administration [22]. Similar to the 
above study, Ramos et al. observed that supplementation of the active 
principle HCA significantly increased HDL-C levels with a decrease 
in LDL levels [21]. Preuss et al. showed that HCA salt at 4.7 g/day in 
moderately obese subjects was capable of reducing food intake, TC, 
TG, and LDL levels while significantly increasing the levels of HDL and 
urinary excretion of fat metabolites [23]. Koshy et al. concluded that the 
flavonoid-rich rind extract exhibited hypolipidemic effect probably by 
lowering lipid turnover and increased metabolism [24].
The observation done by Leonhardt et al. was contradicting with our 
study findings, which showed supplementation of 3% HCA did not 
result in decreased cholesterol levels [25]. Brandt et al. (2006) noted 
HCA (1.8%) supplementation for 4 weeks resulted in an unexpected 
increase in liver lipid and postprandial cholesterolemia [26]. This may 
be due to an insufficient dose of HCA, which has failed to lower the 
serum lipids levels.
Fig. 2: Effect of the rind extract of Garcinia gummi-gutta on 
liver histopathology. Microphotograph of (a) normal liver, 
(b) hyperlipidemic diet, (c) REGG at 100 mg/kg, (D) REGG at 
200 mg/kg, (e) standard control
a b c
d e
Fig. 3: Effect of the rind extract of Garcinia gummi-gutta on 
myocardial histopathology. Microphotograph of (a) normal 
myocardium, (b) hyperlipidemic diet, (c) REGG at 100 mg/kg, (d) 
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Oxidative stress induced by HLD is associated with peroxidation of both 
cellular and circulating lipids which results in the formation of MDA. 
Quantifying this MDA will positively reflect the severity of an ongoing 
oxidative damage treatment with fruit rind extract of G. gummi-gutta 
significantly reduced the TBARS level in a dose-dependent manner. The 
increase in the MDA which is indicative of ongoing oxidative damage was 
due to oxidative stress induced by HLD [27]. In our study, a significant 
reduction in TBARS values was observed following treatment with the 
extract, wherein the maximum reduction was evident with a higher 
dose of the extract. Thus, it is evident that the rind extract possesses 
antioxidant properties at both doses, wherein the extract at higher 
dose exhibited strong antioxidant action compared to other groups. 
Our study findings were consistent with previous studies conducted by 
Kolodziejczyk et al. who in his study concluded that polyisoprenylated 
benzophenones such as garcinol and guttiferone K effectively reduced 
lipid peroxidation of LDL residues (reduced TBARS values), thereby 
indirectly counteracting oxidative stress in hyperlipidemia [28].
In our study, most of the histopathological findings were consistent 
with the obtained biochemical parameters. The fruit rind extract 
at both doses significantly reduced micro fatty deposits, periportal 
leukocytic infiltration, and disrupted architecture with higher doses 
showing evidence of hepatocellular recovery. REGG groups at both 
doses failed to show significant pathological changes in the myocardial 
cells. This may be due to the fact that hyperlipidemia primarily involves 
the vascular system and myocardial involvement in hyperlipidemia 
may be a late phenomenon. In our study, the fruit rind extracts at both 
the doses have effectively protected the myocardial cells from even the 
minor toxic insults of lipid peroxidation (signs of inflammation and 
fatty degeneration).
CONCLUSION
The present study demonstrated the hypolipidemic activity of 
G. gummi-gutta. The fruit rind extract at both doses was able to decrease 
the elevated serum lipids (TC, TG, LDL, and VLDL) and increase the HDL 
levels in a dose-dependent manner in spite of daily administration of HLD.
This reduction in lipid profile and TBARS may be probably due to 
the presence of HCA and other antioxidants in the extracts. Hence, 
further studies are warranted both in animals and humans before 
recommending for the clinical use in humans in the prevention and 
treatment of hyperlipidemia.
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